GHK-Cu for scientific research in the EU is offered by Molequa with FedEx delivery in 1 to 3 business days across Slovakia, Czechia and the EU
Two gaps in whats publicly stated: an individual prescriber name we can verify in CMS NPPES, and which pharmacy class (503A vs 503B) the clinic uses
Mechanism of Action: The Tri-Peptide Synergy
HHcy generally correlated with cumulative LDopa dose without significant association with vitamin levels (Mancini et al
The basic science makes sense and is why theres interest in exploring KPV to help with inflammation, gut health, and skin support
There is no published GLP repeat-dose toxicology study in two species, no genotoxicity battery, no reproductive-toxicity data, no carcinogenicity study, and no published Phase 1 dose-escalation safety profile in humans meeting contemporary regulatory standards